PremiumCompany AnnouncementsCARsgen’s CT071 Research Accepted for Presentation at EHA Congress CARsgen Therapeutics Grants Options to Boost Employee Engagement CARsgen Therapeutics Announces 2025 Annual General Meeting Agenda PremiumCompany AnnouncementsCARsgen Reports Positive Trial Results for Cancer Therapy CARsgen Strengthens Financial Oversight with New Audit Committee CARsgen Showcases Promising CAR T-Cell Therapy Advances PremiumCompany AnnouncementsCARsgen Therapeutics Reports Promising Interim Results CARsgen Advances Pivotal Cancer Treatment Trial CARsgen Therapeutics Sets Date for Financial Review